Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2966) 2966
Newspaper Article (163) 163
Patent (53) 53
Book / eBook (46) 46
Book Review (41) 41
Book Chapter (40) 40
Magazine Article (40) 40
Transcript (27) 27
Conference Proceeding (13) 13
Dissertation (11) 11
Publication (9) 9
Web Resource (5) 5
Reference (4) 4
Report (3) 3
Journal / eJournal (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1631) 1631
life sciences & biomedicine (1558) 1558
humans (1440) 1440
female (920) 920
male (879) 879
middle aged (744) 744
biological and medical sciences (690) 690
adult (675) 675
aged (632) 632
medical sciences (610) 610
oncology (547) 547
abridged index medicus (485) 485
hematology (436) 436
treatment outcome (350) 350
aged, 80 and over (343) 343
adolescent (287) 287
hematologic and hematopoietic diseases (267) 267
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (258) 258
research (248) 248
prognosis (244) 244
antineoplastic combined chemotherapy protocols - therapeutic use (203) 203
risk factors (192) 192
antineoplastic agents - therapeutic use (184) 184
care and treatment (175) 175
pharmacology. drug treatments (175) 175
leukemia, lymphocytic, chronic, b-cell - drug therapy (168) 168
analysis (165) 165
social sciences (160) 160
chemotherapy (157) 157
young adult (157) 157
tumors (152) 152
animals (150) 150
follow-up studies (148) 148
antineoplastic agents (146) 146
cancer (144) 144
leukemia (138) 138
survival rate (138) 138
remission induction (136) 136
child (134) 134
health aspects (128) 128
survival analysis (128) 128
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (124) 124
time factors (115) 115
chronic lymphocytic leukemia (114) 114
disease-free survival (113) 113
pyrimidines - therapeutic use (113) 113
hemic and lymphatic diseases (107) 107
general & internal medicine (104) 104
child, preschool (102) 102
fundamental and applied biological sciences. psychology (100) 100
imatinib mesylate (100) 100
infectious diseases (100) 100
recurrence (100) 100
patients (96) 96
antineoplastic combined chemotherapy protocols - adverse effects (94) 94
retrospective studies (93) 93
drug administration schedule (92) 92
medicine, general & internal (92) 92
neurosciences & neurology (91) 91
children (90) 90
drug therapy (90) 90
benzamides (89) 89
medical research (89) 89
hematology, oncology and palliative medicine (86) 86
psychology (86) 86
disease progression (85) 85
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (84) 84
antineoplastic agents - adverse effects (83) 83
chronic myeloid leukemia (80) 80
genetic aspects (79) 79
microbiology (77) 77
vidarabine - analogs & derivatives (77) 77
clinical trials (75) 75
cohort studies (75) 75
rituximab (75) 75
cytarabine - administration & dosage (74) 74
immunology (74) 74
protein kinase inhibitors - therapeutic use (74) 74
patient outcomes (73) 73
survival (73) 73
clinical neurology (72) 72
united states (72) 72
infant (70) 70
prospective studies (69) 69
antineoplastic agents - administration & dosage (68) 68
studies (68) 68
leukemia, lymphocytic, chronic, b-cell - mortality (67) 67
piperazines - therapeutic use (67) 67
pyrimidines - administration & dosage (67) 67
cyclophosphamide - administration & dosage (65) 65
dose-response relationship, drug (65) 65
age factors (64) 64
diagnosis (64) 64
leukemia, myeloid, acute - drug therapy (62) 62
pediatrics (61) 61
cell biology (60) 60
leukemia, lymphocytic, chronic, b-cell - pathology (60) 60
mutation (60) 60
dosage and administration (59) 59
usage (59) 59
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (18) 18
Gerstein Science - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
UofT at Mississauga - Stacks (7) 7
Online Resources - Online (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
UofT at Scarborough - Stacks (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Regis College - Stacks (2) 2
UofT Schools - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Faculty of Information - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
OISE - WERC (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trillium Health Centre - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3421) 3421
French (12) 12
Japanese (3) 3
German (2) 2
Italian (1) 1
Latin (1) 1
Russian (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
by Tefferi, Ayalew, MD and Kantarjian, Hagop, MD and Rajkumar, S. Vincent, MD and Baker, Lawrence H., DO and Abkowitz, Jan L., MD and Adamson, John W., MD and Advani, Ranjana Hira, MD and Allison, James, MD and Antman, Karen H., MD and Bast, Robert C., MD and Bennett, John M., MD and Benz, Edward J., MD and Berliner, Nancy, MD and Bertino, Joseph, MD and Bhatia, Ravi, MD and Bhatia, Smita, MD and Bhojwani, Deepa, MD and Blanke, Charles D., MD and Bloomfield, Clara D., MD and Bosserman, Linda, MD and Broxmeyer, Hal E., PhD and Byrd, John C., MD and Cabanillas, Fernando, MD and Canellos, George Peter, MD and Chabner, Bruce A., MD and Chanan-Khan, Asher, MD and Cheson, Bruce, MD and Clarkson, Bayard, MD and Cohn, Susan L., MD and Colon-Otero, Gerardo, MD and Cortes, Jorge, MD and Coutre, Steven, MD and Cristofanilli, Massimo, MD and Curran, Walter J., MD and Daley, George Q., MD, PhD and DeAngelo, Daniel J., MD, PhD and Deeg, H. Joachim, MD and Einhorn, Lawrence H., MD and Erba, Harry P., MD, PhD and Esteva, Francisco J., MD, PhD and Estey, Elihu, MD and Fidler, Isaiah J., DVM, PhD and Foran, James, MD and Forman, Stephen, MD and Freireich, Emil, MD and Fuchs, Charles, MD, MPH and George, James N., MD and Gertz, Morie A., MD and Giralt, Sergio, MD and Golomb, Harvey, MD and Greenberg, Peter, MD and Gutterman, Jordan, MD and Handin, Robert I., MD and Hellman, Samuel, MD and Hoff, Paulo Marcelo, MD and Hoffman, Ronald, MD and Hong, Waun Ki, MD and Horowitz, Mary, MD, MS and Hortobagyi, Gabriel N., MD and Hudis, Clifford, MD and Issa, Jean Pierre, MD and Johnson, Bruce Evan, MD and Kantoff, Philip W., MD and Kaushansky, Kenneth, MD and Khayat, David, MD, PhD and Khuri, Fadlo R., MD and Kipps, Thomas J., MD, PhD and Kripke, Margaret, PhD and Kyle, Robert A., MD and Larson, Richard A., MD and Lawrence, Theodore S., MD, PhD and Levine, Ross, MD and Link, Michael P., MD and Lippman, Scott M., MD and Lonial, Sagar, MD and Lyman, Gary H., MD, MPH and Markman, Maurie, MD and Mendelsohn, John, MD and Meropol, Neal J., MD and Messinger, Yoav, MD and Mulvey, Therese M., MD and O’Brien, Susan, MD and Perez-Soler, Roman, MD and Pollock, Raphael, MD, PhD and Prchal, Josef, MD and Press, Oliver, MD, PhD and Radich, Jerald, MD and Rai, Kanti, MD and Rosenberg, Saul A., MD and Rowe, Jacob M., MD and Rugo, Hope, MD and Runowicz, Carolyn D., MD and Sandmaier, Brenda M., MD and Saven, Alan, MD and Schafer, Andrew I., MD and Schiffer, Charles, MD and Sekeres, Mikkael A., MD, MS and Silver, Richard T., MD and Siu, Lillian L., MD and Steensma, David P., MD and ...
Mayo Clinic proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Costs | United States - epidemiology | Neoplasms - economics | Humans | Patient Participation | Patient Advocacy | Antineoplastic Agents - economics | Neoplasms - epidemiology | Prescription Fees | Neoplasms - drug therapy | Antimitotic agents | Cancer patients | Patient outcomes | Economic aspects | Dosage and administration | Drug therapy | Antineoplastic agents | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Handbook for social justice in counseling psychology
: leadership, vision, and action
by Toporek, Rebecca
2006, Counseling and Psychotherapy Transcripts, Volume 1, ISBN 1412910072, xi, 617
Counseling psychology | Social justice | Counseling
Book
Details down arrow
3. Full Text Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
by Burger, Jan A, Dr and Keating, Michael J, Prof and Wierda, William G, Prof and Hartmann, Elena, MD and Hoellenriegel, Julia, MS and Rosin, Nathalie Y, PhD and de Weerdt, Iris, MD and Jeyakumar, Ghayathri, MD and Ferrajoli, Alessandra, MD and Cardenas-Turanzas, Marylou, PhD and Lerner, Susan, MS and Jorgensen, Jeffrey L, MD and Nogueras-González, Graciela M, MS and Zacharian, Gracy, MS and Huang, Xuelin, PhD and Kantarjian, Hagop, Prof and Garg, Naveen, MD and Rosenwald, Andreas, Prof and O'Brien, Susan, Prof
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1090 - 1099
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Neoplasm Recurrence, Local - mortality | Patient Selection | Dose-Response Relationship, Drug | Aged, 80 and over | Adult | Female | Pyrazoles - adverse effects | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Kaplan-Meier Estimate | Rituximab | Survival Rate | Treatment Outcome | Neoplasm Recurrence, Local - diagnosis | Disease-Free Survival | Maximum Tolerated Dose | Pyrazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Antibodies, Monoclonal, Murine-Derived - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Antimitotic agents | Monoclonal antibodies | Safety and security measures | Antineoplastic agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
by Topp, Max S, Dr and Gökbuget, Nicola, MD and Stein, Anthony S, MD and Zugmaier, Gerhard, MD and O'Brien, Susan, MD and Bargou, Ralf C, Prof and Dombret, Hervé, MD and Fielding, Adele K, PhD and Heffner, Leonard, MD and Larson, Richard A, Prof and Neumann, Svenja, MD and Foà, Robin, MD and Litzow, Mark, Prof and Ribera, Josep-Maria, Prof and Rambaldi, Alessandro, MD and Schiller, Gary, MD and Brüggemann, Monika, MD and Horst, Heinz A, MD and Holland, Chris, MS and Jia, Catherine, PhD and Maniar, Tapan, MD and Huber, Birgit, PhD and Nagorsen, Dirk, MD and Forman, Stephen J, MD and Kantarjian, Hagop M, Prof
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 57 - 66
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Recurrence | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Age Factors | United States | Humans | Middle Aged | Salvage Therapy | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antibodies, Bispecific - administration & dosage | Adult | Female | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Remission Induction | Antibodies, Bispecific - therapeutic use | Disease-Free Survival | Antibodies, Bispecific - adverse effects | Adolescent | Intention to Treat Analysis | Aged | Infusions, Intravenous | T cells | Adults | Safety and security measures | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
by Kantarjian, Hagop M and DeAngelo, Daniel J and Stelljes, Matthias and Martinelli, Giovanni and Liedtke, Michaela and Stock, Wendy and Gökbuget, Nicola and O’Brien, Susan and Wang, Kongming and Wang, Tao and Paccagnella, M. Luisa and Sleight, Barbara and Vandendries, Erik and Advani, Anjali S
The New England journal of medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 8, pp. 740 - 753
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Sialic Acid Binding Ig-like Lectin 2 - antagonists & inhibitors | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Remission Induction | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Intention to Treat Analysis | Survival Analysis | Adult | Female | Aged | Care and treatment | Usage | Acute lymphocytic leukemia | Diagnosis | Research | Patients | Health aspects | Antibody-drug conjugates | Acute lymphatic leukemia | Calicheamicin | Liver diseases | Leukemia | Minimal residual disease | Lymphatic leukemia | Survival | Clinical outcomes | CD22 antigen | Chemotherapy | Motivation | Medical prognosis | Remission | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
by Neal, David E and Metcalfe, Chris and Donovan, Jenny L and Lane, J. Athene and Davis, Michael and Young, Grace J and Dutton, Susan J and Walsh, Eleanor I and Martin, Richard M and Peters, Tim. J and Turner, Emma L and Mason, Malcolm and Bryant, Richard and Bollina, Prasad and Catto, James and Doherty, Alan and Gillatt, David and Gnanapragasam, Vincent and Holding, Peter and Hughes, Owen and Kockelbergh, Roger and Kynaston, Howard and Oxley, Jon and Paul, Alan and Paez, Edgar and Rosario, Derek J and Rowe, Edward and Staffurth, John and Altman, Doug G and Hamdy, Freddie C and Hamdy, Freddie C and Donovan, Jenny L and Neal, David E and Lane, J. Athene and Metcalfe, Chris and Peters, Tim J and Bollina, Prasad and Doble, Andrew and Doherty, Alan and Gnanapragasam, Vincent and Hughes, Owen and Gillatt, David and Kockelbergh, Roger and Kynaston, Howard and Paul, Alan and Paez, Edgar and Powell, Philip and Prescott, Stephen and Rosario, Derek and Rowe, Edward and Anderson, John B and Aning, Jonathan and Catto, James and Durkan, Garett and Koupparis, Anthony and Leung, Hing and Mariappan, Param and McNeill, Alan and Persad, Raj and Schwaibold, Hartwig and Tulloch, David and Wallace, Michael and Bonnington, Susan and Bradshaw, Lynne and Cooper, Deborah and Elliott, Emma and Herbert, Phillipa and Holding, Peter and Howson, Joanne and Jones, Amanda and Lennon, Teresa and Lyons, Norma and Moody, Hilary and Plumb, Claire and O'Sullivan, Tricia and Salter, Elizabeth and Thompson, Pauline and Tidball, Sarah and Blaikie, Jan and Gray, Catherine and Adam, Tonia and Askew, Sarah and Atkinson, Sharon and Baynes, Tim and Brain, Carole and Breen, Viv and Brunt, Sarah and Bryne, Sean and Bythem, Jo and Clarke, Jenny and Cloete, Jenny and Dark, Susan and Davis, Gill and Rue, Rachael De La and Denizot, Jane and Dewhurst, Elspeth and Dimes, Anna and Dixon, Nicola and Ebbs, Penny and Emmerson, Ingrid and ... and for the ProtecT Study Group and ProtecT Study Grp and ProtecT Study Group
European urology, ISSN 0302-2838, 03/2020, Volume 77, Issue 3, pp. 320 - 330
ProtecT trial | Radical prostatectomy | Active monitoring | Disease progression | Metastasis | Radiotherapy | Prostate cancer | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Clinical trials | Mortality | Analysis | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: The M. D. Anderson and Mayo Clinic experience
by Tam, Constantine S and Shanafelt, Tait D and Wierda, William G and Abruzzo, Lynne V and Van Dyke, Daniel L and O'Brien, Susan and Ferrajoli, Alessandra and Lerner, Susan A and Lynn, Alice and Kay, Neil E and Keating, Michael J
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 5, pp. 957 - 964
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antibodies, Neoplasm - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Chromosomes, Human, Pair 17 - genetics | Chromosomes, Human, Pair 17 - ultrastructure | Antimetabolites, Antineoplastic - administration & dosage | Antibodies, Monoclonal, Humanized | Aged, 80 and over | Adult | Female | Retrospective Studies | Chromosome Deletion | Antibodies, Monoclonal, Murine-Derived | Rituximab | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Alemtuzumab | Antibodies, Neoplasm - administration & dosage | Disease Progression | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
by O'Brien, Susan, Prof and Furman, Richard R, MD and Coutre, Steven E, Prof and Sharman, Jeff P, MD and Burger, Jan A, MD and Blum, Kristie A, MD and Grant, Barbara, MD and Richards, Donald A, MD and Coleman, Morton, Prof and Wierda, William G, MD and Jones, Jeffrey A, MD and Zhao, Weiqiang, MD and Heerema, Nyla A, Prof and Johnson, Amy J, PhD and Izumi, Raquel, PhD and Hamdy, Ahmed, MD and Chang, Betty Y, PhD and Graef, Thorsten, MD and Clow, Fong, ScD and Buggy, Joseph J, PhD and James, Danelle F, MD and Byrd, John C, Prof
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 1, pp. 48 - 58
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Pyrazoles - therapeutic use | Humans | Male | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Agammaglobulinaemia Tyrosine Kinase | Pyrimidines - adverse effects | Aged, 80 and over | Female | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Pyrazoles - adverse effects | Aged patients | Care and treatment | Lymphomas | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights